In-vitro Fertilization Market Trends

  • Report ID: 6483
  • Published Date: Sep 30, 2024
  • Report Format: PDF, PPT

In-vitro Fertilization Market Trends

Growth Drivers

  • Rising success rate of IVF technology: Several individuals and couples are pursuing fertility treatments encouraged by the increasing success rates of IVF technology. As per a press release by the American Society of Reproductive Medicine, in April 2024, the number of babies born from IVF increased from 89,208 in 2021 to 91,771 in 2022. It further states that 2.5% of all births in the U.S. result from successful ART cycles. Advancements in reproductive technologies have significantly increased the chances of successful pregnancies. As IVF becomes more effective and reliable, it boosts patient confidence, leading to a greater demand for these services. This trend is further supported by an increasing number of R&D practices, enhancing precision and safety in fertility treatments.
  • Delayed onset of pregnancies: Career priorities, financial stability, and personal choices are some of the reasons driving the recent trend of delayed pregnancies. This in turn has proven highly beneficial for the in-vitro fertilization market. As more individuals opt to conceive later in life, fertility naturally declines, increasing the need for assisted reproductive technologies like IVF.  This shift in societal norms has contributed to the growing demand for fertility treatments, especially among women in their late 30s and 40s. Additionally, rising awareness of fertility preservation options, such as egg freezing, further supports the use of IVF among individuals planning to conceive later in life. As per an article by BBC, June 2023, HFEA declared that over 4,000 patients froze their eggs in 2021, in comparison to 2,500 in 2019.

Challenges

  • Associated complications with IVF: The treatment can lead to several complications, including multiple pregnancies, which increases the risk of premature birth and low birth weight. OHSS is another potential complication that makes the ovaries swell painfully due to excessive hormone stimulation. Additionally, IVF sometimes results in ectopic pregnancies, where the embryo implants outside the uterus. Multiple IVF cycles can prove to be emotionally and physically draining for several patients. These factors are a threat to the in-vitro fertilization market, leading to lesser adoption rates for the treatment.
  • Associated social stigma, and ethical, and legal issues with IVF: These treatments often face social stigma, particularly in conservative cultures, where infertility is misunderstood or viewed as a taboo. Ethical issues arise concerning embryo selection, freezing, and disposal. Furthermore, legal challenges exist around the use of donor sperm or eggs, surrogacy, and parental rights, which vary by country or region. This further complicates the access and regulation in the IVF market. These factors are restraining the in-vitro fertilization market growth, majorly in developing countries and regions.

In-vitro Fertilization Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.9%

Base Year Market Size (2024)

USD 21.6 billion

Forecast Year Market Size (2037)

USD 42.9 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6483
  • Published Date: Sep 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the in-vitro fertilization market was over USD 21.6 billion.

The market size for the in-vitro fertilization market is projected to reach USD 42.9 billion by the end of 2037 expanding at a CAGR of 5.9% during the forecast period i.e., between 2025-2037.

The major players in the market are Cook Medical, Esco Medical, FUJIFILM Irvine Scientific, Inc., GE HealthCare Technologies, Inc., and others.

In terms of product segment, the equipment segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 30.5% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample